1. Home
  2. AXNX vs PGNY Comparison

AXNX vs PGNY Comparison

Compare AXNX & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXNX
  • PGNY
  • Stock Information
  • Founded
  • AXNX 2012
  • PGNY 2008
  • Country
  • AXNX United States
  • PGNY United States
  • Employees
  • AXNX N/A
  • PGNY N/A
  • Industry
  • AXNX Medical/Dental Instruments
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • AXNX Health Care
  • PGNY Health Care
  • Exchange
  • AXNX Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • AXNX 3.6B
  • PGNY 1.5B
  • IPO Year
  • AXNX N/A
  • PGNY 2019
  • Fundamental
  • Price
  • AXNX $70.30
  • PGNY $16.68
  • Analyst Decision
  • AXNX Hold
  • PGNY Buy
  • Analyst Count
  • AXNX 9
  • PGNY 9
  • Target Price
  • AXNX $70.67
  • PGNY $22.67
  • AVG Volume (30 Days)
  • AXNX 521.3K
  • PGNY 2.9M
  • Earning Date
  • AXNX 10-28-2024
  • PGNY 11-05-2024
  • Dividend Yield
  • AXNX N/A
  • PGNY N/A
  • EPS Growth
  • AXNX N/A
  • PGNY 28.49
  • EPS
  • AXNX N/A
  • PGNY 0.63
  • Revenue
  • AXNX $408,809,000.00
  • PGNY $1,132,996,000.00
  • Revenue This Year
  • AXNX $25.48
  • PGNY $9.77
  • Revenue Next Year
  • AXNX $19.56
  • PGNY $2.51
  • P/E Ratio
  • AXNX N/A
  • PGNY $26.49
  • Revenue Growth
  • AXNX 27.81
  • PGNY 18.33
  • 52 Week Low
  • AXNX $48.30
  • PGNY $13.93
  • 52 Week High
  • AXNX $70.53
  • PGNY $42.08
  • Technical
  • Relative Strength Index (RSI)
  • AXNX 70.24
  • PGNY 39.54
  • Support Level
  • AXNX $70.17
  • PGNY $15.46
  • Resistance Level
  • AXNX $70.33
  • PGNY $16.66
  • Average True Range (ATR)
  • AXNX 0.28
  • PGNY 0.57
  • MACD
  • AXNX 0.04
  • PGNY 0.25
  • Stochastic Oscillator
  • AXNX 83.92
  • PGNY 75.31

About AXNX Axonics Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

About PGNY Progyny Inc.

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Share on Social Networks: